Ibio Inc (IBIO) |
|
1.45 -0.06 (-3.97%)
|
01-21 00:48 |
|
Open: |
1.52 |
Pre. Close: |
1.51 |
|
High:
|
1.5231 |
Low:
|
1.41 |
|
Volume:
|
7,738,020 |
Market Cap:
|
313M |
|
|
|
|
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. The company is headquartered in New York City, New York and currently employs 7 full-time employees. The firm is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The firm's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The firm is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The firm's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
1.524 - 1.531 |
1.531 - 1.537 |
|
Low:
|
1.39 - 1.4 |
1.4 - 1.408 |
|
Close:
|
1.436 - 1.451 |
1.451 - 1.463 |
|
Technical analysis |
as of: 2021-01-20 4:48:28 PM |
|
Overall:
|
  |
| Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 2.18 One year: 2.55 |
| Support: |
Support1: 1.35 Support2: 1.03 |
| Resistance: |
Resistance1: 1.87 Resistance2: 2.18 |
| Pivot: |
1.30  |
| Moving Average: |
MA(5): 1.48 MA(20): 1.27
MA(100): 1.70 MA(250): 1.73 |
| MACD: |
MACD(12,26): 0.04 Signal(9): -0.01 |
| Stochastic oscillator: |
%K(14,3): 53.17 %D(3): 54.63 |
| RSI: |
RSI(14): 55.86 |
| 52-week: |
High: 7.45 Low: 0.23 Change(%): 367.7 |
| Average Vol(K): |
3-Month: 1181327 10-Days: 1799518 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.IBIO has closed below upper band by 28.1%. Bollinger Bands are 29.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Mon, 18 Jan 2021
COVID 19 Impact On Plant-Based Vaccines Market Outlook with Top Industry: Medicago, Inc., iBio, Inc., and Icon Genetics- GmbH - The Courier
Wed, 13 Jan 2021
Ibio Shares Bounce Back Strongly: Should You Buy? - Own Snap
Wed, 13 Jan 2021
Premarket Mover: Ibio Inc (IBIO) Up 18.99% - InvestorsObserver
Tue, 12 Jan 2021
How Will the Market React to Ibio Inc (IBIO) Stock Getting a Bullish Rating - InvestorsObserver
Sun, 10 Jan 2021
Is Ibio (IBIO) A Better Coronavirus Stock Bet For 2021? – Own Snap - Own Snap
Thu, 07 Jan 2021
iBio's (NYSEMKT:IBIO) Wonderful 324% Share Price Increase Shows How Capitalism Can Build Wealth - Simply Wall St
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
174 |
| Shares Float (M) |
117 |
|
% Held by Insiders
|
8.78 |
|
% Held by Institutions
|
11.56 |
|
Shares Short (K)
|
20,000 |
|
Shares Short P. Month (K)
|
7,300 |
Stock Financials |
|
EPS
|
-0.975 |
|
EPS Est This Year
|
-0.150 |
|
EPS Est Next Year
|
-0.200 |
|
Book Value (p.s.)
|
0.040 |
|
Profit Margin
|
|
|
Operating Margin
|
-1138.46 |
|
Return on Assets (ttm)
|
-24.0 |
|
Return on Equity (ttm)
|
-320.6 |
|
Qtrly Rev. Growth
|
-81.8 |
|
Gross Profit (p.s.)
|
0.012 |
|
Sales Per Share
|
0.008 |
|
EBITDA (p.s.)
|
-0.074 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-14 |
|
Levered Free Cash Flow (M)
|
-8 |
Stock Valuations |
|
PE Ratio
|
-1.49 |
|
PEG Ratio
|
|
|
Price to Book value
|
36.25 |
|
Price to Sales
|
193.06 |
|
Price to Cash Flow
|
-18.23 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
